Polyurethane Foam-Pink Pad (RCT) Use in OR
Effectiveness of Polyurethane Foam (Pink Pad) Compared With Mepilex Dressing for Pressure Ulcer Prevention in Operating Room: A Randomized Control Clinical Trial
King Abdullah Medical City
100 participants
Oct 10, 2023
INTERVENTIONAL
Conditions
Summary
King Abdullah medical city has a cardiac center, and a lot of open-heart surgeries are performed there, and both polyurethane foam (pink Pad) and Mepilex dressing are applied to those patients. Therefore, the present study was designed to compare the effects of polyurethane foam (pink Pad) versus Mepilex dressing for prevention of pressure ulcer in operating room.
Eligibility
Inclusion Criteria5
- Subjects ≥ 18.
- Willing to participate.
- Patients undergoing cardiac surgery.
- Patient who is at risk for PU development as measured with Braden scale.
- Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement.
Exclusion Criteria4
- Subjects under 17
- Not consenting to participate
- Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients.
- Patients who are unable to continue the study because of death or change in the care setting.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Both types of intervention will be available in the operating room. Patient will be examined by head nurse of wound management team after the operation then at day 3- and 7-days post operation. The dressing should be removed after 7 days post operation or if there is any clinical indication for removal. If a patient is discharged before 7 days post operation for any reason the head nurse of wound management team will examine the patient before discharge. Follow up will be for maximum 7 days post operation for each subject. Any patient will be unable to continue the study because of death or change in the care setting will be excluded from the study.
Both types of intervention will be available in the operating room. Patient will be examined by head nurse of wound management team after the operation then at day 3- and 7-days post operation. The dressing should be removed after 7 days post operation or if there is any clinical indication for removal. If a patient is discharged before 7 days post operation for any reason the head nurse of wound management team will examine the patient before discharge. Follow up will be for maximum 7 days post operation for each subject. Any patient will be unable to continue the study because of death or change in the care setting will be excluded from the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06790277